Citius Pharmaceuticals logo
Citius Pharmaceuticals CTXR
$ 0.51 4.08%
report update icon

Quarterly report 2026-Q2
added 05-15-2026

Citius Pharmaceuticals Total Shareholders Equity | CTXR

Annual Total Shareholders Equity Citius Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
67.6 M 70.1 M 90.8 M 103 M 132 M 33.7 M 24.4 M 27.9 M 21.9 M 16.8 M -635 K -742 K -2.9 M -1.61 M -23.8 K 2.5 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
132 M -2.9 M 36.4 M

Quarterly Total Shareholders Equity Citius Pharmaceuticals

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
61.5 M 80 M 80 M 67.6 M 65.1 M 60.7 M 68.9 M 70.1 M 86.3 M 80 M 85.3 M 90.8 M 98.3 K 91.8 M 101 M 103 M 110 M 118 M 125 M 132 M 137 M 126 M 25.8 M 33.7 M 33.7 M 25.2 M 23.2 M 27.2 M 20.4 M 20.4 M 27 M 24.2 M 24.2 M 24.2 M 25.9 M 21.9 M 21.9 M 25.9 M 15.2 M 16.8 M 16.8 M 16.8 M -1.59 M -635 K -635 K -635 K -824 K -742 K -742 K -742 K -2.9 M -14.7 K -14.7 K -15 K -1.61 M -45.8 K -45.8 K -47.3 K -1.06 M -23.8 K -23.8 K -26.4 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
137 M -2.9 M 38.7 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer Total Shareholders Equity Price % 24h Market Cap Country
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
112 M - - $ 401 M usaUSA
Histogen Histogen
HSTO
14.4 M - 31.6 % $ 2.12 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
-12.6 M - - $ 169 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
-279 M - -7.23 % $ 13 M usaUSA
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
1.73 B - - $ 1.62 B israelIsrael
Omeros Corporation Omeros Corporation
OMER
-121 M $ 13.23 -5.71 % $ 840 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
23.3 M $ 0.94 -10.44 % $ 2.32 B israelIsrael
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
-93 M - 7.4 % $ 6.29 M usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
498 M - - $ 958 M usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
299 M - - $ 8.14 B usaUSA
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
5.07 B - - $ 26.6 B irlandaIrlanda
Provention Bio Provention Bio
PRVB
122 M - - $ 2.37 B usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
-65.7 M - - $ 6.29 B usaUSA
PainReform Ltd. PainReform Ltd.
PRFX
8.54 M $ 0.47 -24.53 % $ 305 K israelIsrael
iTeos Therapeutics iTeos Therapeutics
ITOS
590 M - - $ 411 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
5.59 M $ 1.44 -2.03 % $ 2.37 M israelIsrael
PolarityTE PolarityTE
PTE
16.6 M - -0.82 % $ 1.78 M usaUSA
Kronos Bio Kronos Bio
KRON
87.6 M - 1.49 % $ 50.8 M usaUSA
Cullinan Management Cullinan Management
CGEM
409 M $ 8.9 -1.93 % $ 536 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.92 B $ 39.15 0.57 % $ 3.52 B schweizSchweiz
Advaxis Advaxis
ADXS
-24.4 M - -9.65 % $ 45.9 M usaUSA
Stoke Therapeutics Stoke Therapeutics
STOK
352 M $ 26.77 -0.59 % $ 1.59 B usaUSA
Trevena Trevena
TRVN
-7.66 M - -46.58 % $ 31.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
20.4 M - -10.95 % $ 876 K usaUSA
Molecular Templates Molecular Templates
MTEM
4.21 M - -23.43 % $ 495 K usaUSA
Oncorus Oncorus
ONCR
60.5 M - -8.54 % $ 3.19 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
-95.5 M $ 0.07 9.81 % $ 855 K usaUSA
Novan Novan
NOVN
4.6 M - -24.84 % $ 2.64 M usaUSA
CohBar CohBar
CWBR
15.3 M - -15.44 % $ 2.2 M usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
18.2 M - -1.56 % $ 12.3 M usaUSA
Epizyme Epizyme
EPZM
-20.7 M - - $ 249 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
673 M - -6.81 % $ 3.04 B usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
-6.56 M - -48.37 % $ 3.71 M usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
3.29 M - - $ 4.55 M irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
16.9 M $ 0.71 -3.81 % $ 14.6 M usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
13.3 M - - $ 218 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
31.2 M - - $ 105 M usaUSA
Athersys Athersys
ATHX
-23.9 M - 3.77 % $ 22.4 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
196 M - - $ 4.62 B usaUSA
Inozyme Pharma Inozyme Pharma
INZY
57.8 M - - $ 207 M usaUSA
NanoString Technologies NanoString Technologies
NSTG
45.8 M - -37.43 % $ 5.1 M usaUSA
Humanigen Humanigen
HGEN
-46.8 M - -81.12 % $ 4.28 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
4.52 M $ 3.56 -9.07 % $ 1.58 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
-18.6 M - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
93.4 M - - $ 59.7 M usaUSA
Sierra Oncology Sierra Oncology
SRRA
96 M - -0.05 % $ 1.34 B canadaCanada
Vaccinex Vaccinex
VCNX
-2.49 M - -61.37 % $ 654 K usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
-6.78 M - -19.68 % $ 18.4 M canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
183 M - - $ 98.4 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
6.33 M $ 0.93 -4.11 % $ 10.5 M usaUSA